Frontiers in Medicine (Aug 2023)

A posteriori diagnosis of DRESS syndrome induced by diazoxide in a patient with an insulinoma: a case report and review of the literature

  • Najoua Lassoued,
  • Najoua Lassoued,
  • Wafa Alaya,
  • Sondos Arfa,
  • Mouna Korbi,
  • Ines Lassoued,
  • Soumaya Ben Amor,
  • Fatma Zaouali,
  • Zayneb Farhat,
  • Jihen Chelly,
  • Mohamed Habib Sfar

DOI
https://doi.org/10.3389/fmed.2023.1196041
Journal volume & issue
Vol. 10

Abstract

Read online

The Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome can be potentially life-threatening. The diagnosis is sometimes difficult since the clinical manifestations may be incomplete or non-specific. Insulinoma is a rare functioning neuroendocrine tumor (NET) of the pancreas. Medical therapy may be needed when surgery is contraindicated, delayed or refused. Diazoxide is widely used to control hypoglycemia in patients with insulinoma. We report a clinical case of an insulinoma in a 85-year-old patient treated with diazoxide with a fatal outcome due to a delayed diagnosis of a DRESS syndrome. This is the first case of DRESS syndrome reported after using diazoxide for insulinoma treatment in our knowledge.

Keywords